指南与共识头颈神经MR

头颈部鳞癌MRI治疗后监测:拟议MR NI-RADS标准

MRI Posttreatment Surveillance for Head and Neck Squamous Cell Carcinoma: Proposed MR NI-RADS Criteria.
PubMed 文献 · AJNR Am J Neuroradiol · 2021-03-11

本研究回顾性纳入69例头颈鳞癌患者,在1.5T MRI治疗后监测中,将DWI和T2信号特征加入ACR NI-RADS形态学词典进行再评分。结果显示联合DWI和T2的拟议标准较单独NI-RADS词典在原发灶评估中具有更高的敏感度、特异度、阳性预测值、阴性预测值和准确率。

要点

  • 拟议MR NI-RADS标准在ACR NI-RADS形态学基础上增加DWI和T2信号作为修改规则。
  • 联合DWI和T2评估原发灶的敏感度92.3%、特异度90.7%、AUC未报告。
  • 单独ACR NI-RADS词典的敏感度84.6%、特异度81.4%,联合标准各指标均更高。

关键影像表现/征象

  • 采用T2信号强度和扩散特征作为修改规则对治疗后头颈鳞癌原发灶进行NI-RADS再评分。

诊断标准与关键数值

  • 拟议标准(T2信号+扩散特征联合NI-RADS)评估原发灶:敏感度92.3%、特异度90.7%、阳性预测值85.7%、阴性预测值95.1%、准确率91.3%。
  • 单独当前ACR NI-RADS词典评估原发灶:敏感度84.6%、特异度81.4%、阳性预测值73.3%、阴性预测值89.8%、准确率82.6%。

临床应用与阅片要点

  • 对头颈鳞癌治疗后MRI监测,可在ACR NI-RADS形态学词典基础上增加DWI和T2信号特征进行再评分。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The current Neck Imaging Reporting and Data System (NI-RADS) criteria were designed for contrast-enhanced CT with or without PET. Prior studies have revealed the capability of DWI and T2 signal intensity in distinguishing locoregional tumor residual and recurrence from posttreatment benign findings in head and neck cancers. We aimed to propose MR imaging NI-RADS criteria by adding diffusion criteria and T2 signal intensity to the American College of Radiology NI-RADS template.

MATERIALS AND METHODS: This retrospective study included 69 patients with head and neck squamous cell carcinoma (HNSCC) who underwent posttreatment contrast-enhanced MRI imaging surveillance using a 1.5T scanner. The scans were interpreted by 2 neuroradiologists. Image analysis assessed the primary tumor site using the current American College of Radiology NI-RADS morphologic lexicon (mainly designed for contrast-enhanced CT with or without PET). NI-RADS rescoring was then performed based on our proposed criteria using T2 signal and diffusion features. The reference standard was a defined set of criteria, including clinical and imaging follow-up and pathologic assessment.

RESULTS: Imaging assessment of treated HNSCC at the primary tumor site using T2 signal intensity and diffusion features as modifying rules to NI-RADS showed higher sensitivity, specificity, positive predictive value, negative predictive value, and accuracy (92.3%, 90.7%, 85.7%, 95.1%, and 91.3%, respectively) compared with the current NI-RADS lexicon alone (84.6%, 81.4%, 73.3%, 89.8%, and 82.6%, respectively).

CONCLUSIONS: The addition of diffusion features and T2 signal to the American College of Radiology NI-RADS criteria for the primary tumor site enhances the specificity, sensitivity, positive predictive value, negative predictive value, and NI-RADS accuracy.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Ashour MM, Darwish EAF, Fahiem RM, et al. MRI Posttreatment Surveillance for Head and Neck Squamous Cell Carcinoma: Proposed MR NI-RADS Criteria. AJNR Am J Neuroradiol. 2021. PMID: 33707288. doi:10.3174/ajnr.A7058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。